1993
Glucocorticoid suppression of human placental fibronectin expression: implications in uterine-placental adherence
Guller S, Wozniak R, Krikun G, Burnham J, Kaplan P, Lockwood C. Glucocorticoid suppression of human placental fibronectin expression: implications in uterine-placental adherence. Endocrinology 1993, 133: 1139-1146. DOI: 10.1210/en.133.3.1139.Peer-Reviewed Original ResearchTreatment of cytotrophoblastsIncreased levels of glucocorticoidsEffects of glucocorticoidsHuman term placentaLevels of glucocorticoidsPlacental functionExtracellular matrix protein synthesisHuman parturitionAssociated with parturitionTerm placentaMultiple extracellular matrix proteinsPlacental fibronectinDexamethasone treatmentCytotrophoblastMatrix protein synthesisDexamethasoneGlucocorticoidExtracellular matrix proteinsCell-associated materialImmunoprecipitation studiesOnfFNLevels of total proteinMessenger RNANorthern blottingOncofetal epitope
1992
Growth hormone and fibronectin expression in 3T3 preadipose cells.
Guller S, Allen D, Corin R, Lockwood C, Sonenberg M. Growth hormone and fibronectin expression in 3T3 preadipose cells. Endocrinology 1992, 130: 2609-2616. DOI: 10.1210/en.130.5.2609.Peer-Reviewed Original ResearchInsulin-like growth factor-1Growth factor-1Fibronectin expressionGH actionPreadipose cellsFactor 1Function of GHFibronectin protein expressionLevels of fibronectin mRNASerum-free mediumFibronectin messenger RNAGH treatmentExtracellular matrixFibronectin levelsWestern blot analysisDose-dependentlyDay 1GH effectsGrowth hormoneFibronectin mRNAMRNA expressionProtein expressionGlycerol-3-phosphate dehydrogenase activityImmunoprecipitation studiesControl cells